NASDAQ: ATRC · Industrial Applications and Services · 5 alerts · CIK 1323885
Share price
$55.31Close, Nov 16
Market cap
$2.82B
Shares outstanding
50.92MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All AtriCure, Inc. filings on SEC EDGAR ↗
AtriCure Insider B. Kristine Johnson Sells $143K of Stock
B. Kristine Johnson sold 2,452 shares of AtriCure, Inc. at $58.48 a share, worth $143K in total on Nov 6, 2026. Shares held after the trade: 53,502 (-4.4%).
AtriCure Chief Technical Officer Salvatore Privitera Sells $546K of Stock
Salvatore Privitera, Chief Technical Officer, sold 8,404 shares of AtriCure, Inc. at $65.00 a share, worth $546K in total on Nov 4, 2026. Shares held after the trade: 134,341 (-5.9%).
AtriCure, Inc. reported a significant turnaround for the nine months ended September 30, 2026, achieving a net income of $13.1 million compared to a net loss of $13.2 million in the prior year period. Revenue grew 14% year-over-year to $449.3 million, driven by strong performance in surgical treatments for atrial fibrillation and left atrial appendage management.
AtriCure reported third quarter 2026 worldwide revenue of $154.5 million, a 15% year-over-year increase driven by strong U.S. sales in post-operative pain management and appendage management. The company achieved profitability expansion with net income of $4.1 million and adjusted EBITDA of $26.8 million, while raising its full-year 2026 revenue guidance to a range of $606 million to $610 million.
Term
Q3 2026
“Our third quarter results demonstrate the strength of our broad portfolio and our team’s disciplined execution. Adoption of our innovative technologies is driving strong growth and expanding profitability, while the rapid progress of our BoxX-NoAF clinical trial reinforces our confidence in the opportunities ahead.”
Michael Carrel, President and Chief Executive Officer